ArticleBMJ open respiratory research2018

Investigating the effects of nintedanib on biomarkers of extracellular matrix turnover in patients with IPF: design of the randomised placebo-controlled INMARK®trial.

Toby M Maher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.